SCHEMBL3564907

SCHEMBL3564907

Clc1ccc(-c2cc(Cl)nc(Cl)n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
L3MBTL1 Q9Y468 3/20 0.54
HPGD P15428 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
KDM4E B2RXH2 4/20 0.48
MAPT P10636 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
HSP90AA1 P07900 1/20 0.46
HSP90AB1 P08238 1/20 0.46
CTRC Q99895 2/20 0.43
HSD17B10 Q99714 1/20 0.43
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
ADORA3 P0DMS8 1/20 0.40
METAP2 P50579 1/20 0.39
NOTUM Q6P988 1/20 0.39
KDM5B Q9UGL1 1/20 0.39
MGAM O43451 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10051515 0.93 MEN1 (0.60) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL908398 0.85 MEN1 (0.52) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL29511675 0.83 MEN1 (0.73) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL3450627 0.83 KDM4E (0.70) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL7381830 0.83 MEN1 (0.73) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL413907 0.83 MEN1 (0.79) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL15395065 0.81 MEN1 (0.83) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL21058802 0.80 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL1256026 0.79 L3MBTL1 (0.55) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL3951575 0.79 HSP90AB1 (0.72) ALDH1A1MEN1KMT2ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114369097-B Heteroaromatic AhR inhibitors 山东轩竹医药科技有限公司 2023-07-14 CN disclosed
US-20230150970-A1 AMINOPYRIMIDINE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS DONG-A ST CO., LTD. (KR) 2023-05-18 US disclosed
US-20230150970-A1 AMINOPYRIMIDINE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS DONG-A ST CO., LTD. (KR) 2023-05-18 US disclosed
US-20230150970-A1 AMINOPYRIMIDINE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS DONG-A ST CO., LTD. (KR) 2023-05-18 US disclosed
EP-4126839-A1 AMINOPYRIMIDINE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS Dong-A ST Co., Ltd. (KR) 2023-02-08 EP disclosed
CN-115397818-A Aminopyrimidine derivatives and their use as modulators of arene receptors 东亚ST株式会社 2022-11-25 CN disclosed
WO-2022078356-A1 HETEROAROMATIC AHR INHIBITOR 山东轩竹医药科技有限公司 2022-04-21 WO disclosed
WO-2022078356-A1 HETEROAROMATIC AHR INHIBITOR 山东轩竹医药科技有限公司 2022-04-21 WO disclosed
CN-114369097-A Heteroaromatic AhR inhibitors 山东轩竹医药科技有限公司 2022-04-19 CN disclosed
EP-2001849-B1 PYRIDINE AND PYRIMIDINE DERIVATIVES AS MGLUR2 ANTAGONISTS HOFFMANN LA ROCHE (CH) 2014-11-26 EP disclosed
US-8183262-B2 Central nervous system disorders; metabotropic glutamate receptors (mGluR); 2-(4-Pyridin-3-yl-imidazol-1-yl)-4-trifluoromethyl-6-(4-trifluoromethyl-phenyl)-pyrimidine HOFFMANN-LA ROCHE INC. (US) 2012-05-22 US disclosed
US-7642264-B2 Phenyl-substituted pyrimidine derivatives as mGluR antagonists HOFFMAN-LA ROCHE INC. (US) 2010-01-05 US disclosed
US-20090318474-A1 PYRIDINE AND PYRIMIDINE DERIVATIVES AS MGLUR 2 ANTAGONISTS GATTI MCARTHUR SILVIA 2009-12-24 US disclosed
EP-2001849-A1 PYRIDINE AND PYRIMIDINE DERIVATIVES AS MGLUR2 ANTAGONISTS F. Hoffmann-Roche AG (CH) 2008-12-17 EP disclosed
US-20070232583-A1 Pyridine and pyrimidine derivatives as mGIuR2 antagonists HOFFMANN-LA ROCHE INC. 2007-10-04 US disclosed
WO-2007110337-A1 PYRIDINE AND PYRIMIDINE DERIVATIVES AS MGLUR2 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2007-10-04 WO disclosed
US-6440984-B1 PROTECTION FOR GROWING AND HARVESTED CROPS; CONTROLLING TOBACCO BUDWORMS AND SOUTHERN ARMYWORMS; PESTICIDES; INSECTICIDES; MITICIDES; ANTHELMINTICS BASF AKTIENGESELLSCHAFT (DE) 2002-08-27 US disclosed
US-20020045634-A1 Use of aryl-substituted pyrimidines as insecticidal and acaricidal agents AMERICAN CYANAMID COMPANY 2002-04-18 US disclosed
US-6306866-B1 2-ALKOXY SUBSTITUTED PYRIMIDINE DERIVATIVES AMERICAN CYANAMID COMPANY 2001-10-23 US disclosed
US-6153619-A Aryl-substituted pyrimidines as insecticidal and acaricidal agents AMERICAN CYANAMID COMPANY (US) 2000-11-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232583-A1 Pyridine and pyrimidine derivatives as mGIuR2 antagonists P2RX2, P2RY2, P2RX1 ALDH1A1 1138/4885MEN1 2469/4885KMT2A 2308/4885
US-20090318474-A1 PYRIDINE AND PYRIMIDINE DERIVATIVES AS MGLUR 2 ANTAGONISTS GRM2, GRM1, GRM3 ALDH1A1 3286/4885MEN1 4541/4885KMT2A 1588/4885
US-20020045634-A1 Use of aryl-substituted pyrimidines as insecticidal and acaricidal agents YBX1, YBX3, CYP1B1 ALDH1A1 161/4885MEN1 4630/4885KMT2A 2262/4885
US-20230150970-A1 AMINOPYRIMIDINE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS AHR, ARNT, AIPL1 ALDH1A1 240/4885MEN1 4872/4885KMT2A 889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.